Inventor

PROCOPIOU PANAYIOTIS ALEXANDROU

GB15 patents

⚠️ This page may combine multiple inventors who share the name “PROCOPIOU PANAYIOTIS ALEXANDROU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GLAXO GROUP LTD

9 patents

US7439393B2Oct 21, 2008

Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases

GLAXO GROUP LTD7 citations73

US7442839B2Oct 28, 2008

Phenethanolamine derivative for the treatment of respiratory diseases

GLAXO GROUP LTD4 citations58

US7884114B2Feb 8, 2011

Compounds

GLAXO GROUP LTD1 citations50

US7538127B2May 26, 2009

Medicinal compounds

GLAXO GROUP LTD1 citations50

US8357716B2Jan 22, 2013

Pyrazole derivatives used as CCR4 receptor antagonists

GLAXO GROUP LTD0 citations49

US7989629B2Aug 2, 2011

3-(4-{ [4-(4-{ [3-(3, 3-dimethyl-1-piperidinyl) propyl] oxy} phenyl)-1-piperidinyl] carbonyl}-1-naphthalenyl) propanoic or propenoic acid as H1 and H3 receptor antagonists for the treatment of inflammatory and/or allergic disorders

GLAXO GROUP LTD1 citations45

GLAXOSMITHKLINE IP DEV LTD

4 patents

US10513517B2Dec 24, 2019

Naphthyridine derivatives as alpha V beta 6 integrin antagonists for the treatment of E.G. fibrotic diseases

GLAXOSMITHKLINE IP DEV LTD11 citations82

US10144733B2Dec 4, 2018

Naphthyridine derivatives as alpha v beta 6 integrin antagonists for the treatment of E.G. fibrotic diseases

GLAXOSMITHKLINE IP DEV LTD5 citations71

US10004724B2Jun 26, 2018

Compounds alpha v beta 6 integrin antagonists

GLAXOSMITHKLINE IP DEV LTD2 citations71

US10487080B2Nov 26, 2019

Naphthyridines as integrin antagonists

GLAXOSMITHKLINE IP DEV LTD3 citations70

BOX PHILIP CHARLES

1 patent

US8198483B2Jun 12, 2012

Phenethanolamine derivatives for treatment of respiratory diseases

BOX PHILIP CHARLES5 citations68

HODGSON SIMON TEANBY

1 patent

US8507543B2Aug 13, 2013

Compounds

HODGSON SIMON TEANBY0 citations43